Bonne Santé Group Executes Strategic Manufacturing Agreement with SolisLabs, LLC
Agreement with Bonne Santé s Manufacturing Subsidiary Provides Critical Manufacturing Capabilities for Expanding SolisLabs Product Line
News provided by
Share this article
Share this article
MIAMI, March 15, 2021 /PRNewswire/ Bonne Santé Group, Inc. and its subsidiary, Bonne Santé Natural Manufacturing, Inc., today announced that it has entered into a strategic agreement with SolisLabs, LLC to manufacture a broad range of SolisLabs products. SolisLabs is a leading nutritional supplement company with a focus on world class dietary supplements. The announcement was made by A.J. Cervantes, Jr., Executive Chairman of Bonne Santé Group and Sarah Whyte, Chief Executive Officer and Founder of SolisLabs.
Bonne Santé Group Executes Strategic Manufacturing Agreement with SolisLabs, LLC prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.